# Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG

> **NCT07438860** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Tiffany Hodges** · enrollment: 12 (estimated)

## Conditions studied

- Malignant Brain Tumors
- Glioma

## Interventions

- **DRUG:** SBK2-ICG
- **PROCEDURE:** Craniotomy (Standard of Care)

## Key facts

- **NCT ID:** NCT07438860
- **Lead sponsor:** Tiffany Hodges
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07438860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07438860, "Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07438860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*